Ranitidine

Dosage ; Peptic ulcer: 300mg nocte 4/52.

Maintenance: 150mg nocte.

Children over 18 years: 150mg BD.

Not recommended for children below 8yrs.

Zollinger-Ellison syndrome: 150mg TDS up to 6g daily if necessary, in divided doses. Inj. Adults: 50mg by slow 1.V inj or inf. or I.M (repeat six or eight hourly)

Ranitidine Brands
Brand Name Manufacturer Name Distributor Drug Strength Packaging Formulation Formulation Strength Price
Labtac Laboratory & Allied Ltd. Laboratory & Allied Ltd 150mg 100 Tablet per tablet KES 175.00
Labtac Laboratory & Allied Ltd. Laboratory & Allied Ltd 25mg 1 Injection per ml KES 18.00
Neotack Square Pharmaceuticals Ltd ACE Pharmaceuticals Ltd 150mg 150 Tablet per tablet KES 400.00
Neotack Square Pharmaceuticals Ltd ACE Pharmaceuticals Ltd 50mg 10 Injection per ml KES 175.00
Ranitidine-Agio Agio Pharmaceuticals Limited Pharma Specialities Ltd. 150mg 100 Tablet per tablet KES 220.00
Reducid Flamingo Pharmaceuticals Ltd. Harley's Limited 150mg 100 Tablet per tablet KES 235.00
R-Loc Zydus Cadila Healthcare C.Mehta & Co Ltd. 150mg 100 Tablet per tablet KES 526
Ultac Cosmos Limited. Cosmos Limited 150mg 20 Tablet per tablet KES 100.00
Zantac Beximco Pharma Madawa Pharmaceuticals Ltd. 150mg 100 Tablet per tablet KES 549.00
Zantac Beximco Pharma Madawa Pharmaceuticals Ltd. 300mg 100 Tablet per tablet KES 549.00
Zantac Beximco Pharma Madawa Pharmaceuticals Ltd. 300mg 10 Tablet per tablet KES 900.50
Zantac Beximco Pharma Madawa Pharmaceuticals Ltd. 50mg 5 Injection per ml KES 225.00
Aciloc Cadila Pharmaceuticals Ltd. Cadila Pharmaceuticals (EA) 150mg 100 Tablet per tablet KES 900.00
Aciloc Cadila Pharmaceuticals Ltd. Cadila Pharmaceuticals (EA) 300mg 100 Tablet per tablet KES 1,300.00
Aciloc Cadila Pharmaceuticals Ltd. Cadila Pharmaceuticals (EA) 50mg 5 Injection per vial KES 120.00
Reduced Flamingo Pharmaceuticals Ltd. Harley's Limited 150mg 100 Tablet per tablet KES 204.00
Neoceptin R Beximco Pharma Madawa Pharmaceuticals Ltd. 150mg 100 Tablet per tablet KES 549.00
Neoceptin R Beximco Pharma Madawa Pharmaceuticals Ltd. 300mg 100 Tablet per tablet KES 1,800.00
Ranidin Acme Laboratories Ltd Unisel Pharma (K) Ltd. 50mg 10 Injection per vial KES 180.00
Rani Denk Denk Pharma Laborex Kenya Eurapharma Ltd 150mg 20 Tablet per tablet KES 470.59
Ranitin Torrent Pharmaceuticals Ltd. Medox Pharmaceuticals Ltd. 150mg 100 Tablet per tablet KES 500.00
Ranitin Torrent Pharmaceuticals Ltd. Medox Pharmaceuticals Ltd. 300mg 100 Tablet per tablet KES 900.00
Ranitin Torrent Pharmaceuticals Ltd. Medox Pharmaceuticals Ltd. 25mg 5 Injection per vial KES 225.00
Zantac GlaxoSmithkline GlaxoSmithKline 150mg 20 Tablet per tablet KES 869.60
Zantac GlaxoSmithkline GlaxoSmithKline 300mg 10 Tablet per tablet KES 766.30
Zantac GlaxoSmithkline GlaxoSmithKline 150mg 10 Tablet per tablet KES 642.80
Zantac GlaxoSmithkline GlaxoSmithKline 50mg 5 Injection per vial KES 830.90
Zerocid Synermed Pharmaceuticals Ltd Saicare Enterprises Ltd. 25mg 5 Injection per vial KES 100.00

Ranitidine More info

Mode Of Action

Histamine H2-receptor antagonist

Drug Indication Duodenal ulcers, benign gastric ulcers, and prevention of peptic ulcers associated with NSAIDs, reflux oesophagitis, Zollinger-Ellison syndrome
Precautions No protection against NSAID associated ulceration of the stomach, pregnancy and breast-feeding, exclude possibility of malignancy, porphyria, it does not significantly inhibit hepatic microsomal drug metabolism
Contra-Indications No experience in pregnancy and with children
Side Effects Masking of symptoms of gastric cancer, reversible gynaecomastia (weak anti-androgenic effect), alopecia, hepatic disorders, confusional states, galactorrhoea, blood disorders, loss of libido, acute pancreatitis, GI disturbances, skin rashes, cardiac arrhythmias, hypotension, muscular pain, nephritis, hallucinations. Erythema multiforme, less commonly blurred vision, pancreatitis, involuntary move-ment disorders, interstitial nephritis, alopecia. Masking of symptoms of gastric cancer, reversible
Dosage Peptic ulcer: 300mg nocte 4/52. Maintenance: 150mg nocte. Children over 18 years: 150mg BD. Not recommended for children below 8yrs. Zollinger-Ellison syndrome: 150mg TDS up to 6g daily if necessary, in divided doses. Inj. Adults: 50mg by slow 1.V inj or inf. or I.M (repeat six or eight hourly)
Special Information It is suitable for treatment of pediatric reflux. It is preferred to proton pump inhibitors
Pregnancy Category Category B1
Pregnancy Category Description Drugs which have been taken by only a small number of pregnant women and women of child-bearing age with no any established rise in the frequency of malformations or other direct or indirect detrimental effects on the foetus having been noted. Studies in animals have not shown evidence of an increased occurrence of foetal damage.
Drug Category DRUGS ACTING ON ALIMENTARY SYSTEM
Drug Sub-Category H-Antagonists

Dosing: Adult

Duodenal ulcer: Oral: Treatment: 150 mg twice daily, or 300 mg once daily after the evening meal or at bedtime; maintenance: 150 mg once daily at bedtime

Eradication of Helicobacter pylori: Oral: 150 mg twice daily; requires combination therapy

Pathological hypersecretory conditions:

Oral: 150 mg twice daily; adjust dose or frequency as clinically indicated; doses of up to 6 g/day have been used

I.V.: Continuous infusion for Zollinger-Ellison: Initial: 1 mg/kg/hour; measure gastric acid output at 4 hours, if >10 mEq or if patient is symptomatic, increase dose in increments of 0.5 mg/kg/hour; doses of up to 2.5 mg/kg/hour (or 220 mg/hour) have been used

Gastric ulcer, benign: Oral: 150 mg twice daily; maintenance: 150 mg once daily at bedtime

GERD: Oral: 150 mg twice daily

Erosive esophagitis: Oral: Treatment: 150 mg 4 times/day; maintenance: 150 mg twice daily

Prevention of heartburn: Oral: Zantac 75® [OTC]: 75 mg 30-60 minutes before eating food or drinking beverages which cause heartburn; maximum: 150 mg in 24 hours; do not use for more than 14 days

Patients not able to take oral medication:

I.M.: 50 mg every 6-8 hours

I.V.: Intermittent bolus or infusion: 50 mg every 6-8 hours

Continuous I.V. infusion: 6.25 mg/hour

Dosing: Pediatric

(For additional information see "Ranitidine: Pediatric drug information")

Duodenal and gastric ulcer:

Oral: Children 1 month to 16 years:

Treatment: 4-8 mg/kg/day divided twice daily; maximum: 300 mg/day

Maintenance: 2-4 mg/kg/day once daily; maximum: 150 mg/day

I.V.: 2-4 mg/kg/day divided every 6-8 hours; maximum: 200 mg/day

GERD and erosive esophagitis: Children 1 month to 16 years:

Oral: 5-10 mg/kg/day divided twice daily; maximum: GERD: 300 mg/day, erosive esophagitis: 600 mg/day

I.V. (unlabeled): 2-4 mg/kg/day divided every 6-8 hours; maximum: 200 mg/day or as an alternative

Continuous infusion: Initial: 1 mg/kg/dose for one dose followed by infusion of 0.08-0.17 mg/kg/hour or 2-4 mg/kg/day

Prevention of heartburn: Oral: Children ≥12 years: Zantac 75® [OTC]: 75 mg 30-60 minutes before eating food or drinking beverages which cause heartburn; maximum: 150 mg/24 hours; do not use for more than 14 days

Dosing: Geriatric

Refer to adult dosing.

Dosing: Renal Impairment

Adults: Clcr <50 mL/minute:

Oral: 150 mg every 24 hours; adjust dose cautiously if needed

I.V.: 50 mg every 18-24 hours; adjust dose cautiously if needed

Hemodialysis: Adjust dosing schedule so that dose coincides with the end of hemodialysis.

Dosing: Hepatic Impairment

Patients with hepatic impairment may have minor changes in ranitidine half-life, distribution, clearance, and bioavailability; dosing adjustments are not necessary; monitor patient